The breakthrough cancer pain treatment developed by BioDelivery Sciences (NASDAQ:BDSI) International is making progress toward entering the European market, triggering a $2.5 milestone payment from BDSI’s drug partner Meda Pharmaceuticals. The milestone was triggered by registration and pricing approval of the drug Breakyl in Europe. Raleigh, North Carolina-based BDSI is due another $2.5 million upon […]
The clinical trials process is becoming more of an electronic endeavor as the proliferation of data sparks new software to efficiently manage it. But one aspect of these studies has remained manual and slow: payment to the doctors who run the studies. Clinical trials technology company Clinverse has developed cloud-based software that overcomes the payment […]
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
AIDS patients expecting approval of a new HIV-associated diarrhea treatment in June must wait at least another three months for a decision. Salix Pharmaceuticals (NASDAQ:SLXP) had been scheduled for a June 5 decision date on its experimental diarrhea treatment crofelemer. But the Raleigh, North Carolina company said it has been notified by the U.S. Food […]
Amgen‘s (NASDAQ:AMGN) biosimilar drug portfolio will be studied in clinical trials in alliance with clinical research organization PRA. PRA has entered into a strategic partnership with Amgen to do work on a series of phase 3 studies to develop biosimilar drugs. Biosimilars are follow-on biologic drugs that are cheaper than very expensive biologic drugs. No […]
Salix Pharmaceuticals (NASDAQ:SLXP) must wait a little longer for a regulatory decision on its constipation treatment Relistor. An approval decision was expected on April 27. But the U.S. Food and Drug Administration has notified the Raleigh, North Carolina company that it needs more time. The new target date to issue an approval decision is July […]
The saying that the way to a man’s heart is through the stomach might be true in more ways than one. Diagnostics company LipoScience is developing a new cardiovascular disease test that would use gut flora as a biomarker for cardiovascular risks. The novel approach is based on research licensed from the Cleveland Clinic. Researchers […]
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
The cancer products portfolio that DARA BioSciences (NASDAQ:DARA) has been building by acquisition now has more than $9 million in fresh capital to help bring those products to market. The pharmaceutical company has completed a securities offering of preferred stock and warrants, according to securities filings. Raleigh, North Carolina-based DARA sold 10,250 shares of preferred […]
A drug delivery technology patent awarded to BioDelivery Sciences International (NASDAQ:BDSI) has triggered a $15 million milestone payment from drug partner Endo Pharmaceuticals (NASDAQ:ENDP). Raleigh, North Carolina-based BDSI said today that the U.S. Patent and Trademark Office has formally awarded a patent for the company’s “Transmucosal Delivery Devices with Enhanced Uptake,” a patent that covers […]
Early stage life science companies looking to fill a funding gap now have another avenue: a hospital. Rex Healthcare is creating a $10 million fund to invest in healthcare innovations and technologies. This new fund, called Rex Health Ventures, puts the Raleigh, North Carolina hospital among the few hospitals that have created venture capital fund. […]
As drug abuse grows and drug addiction specialists seek new ways to treat opioid dependence, BioDelivery Sciences International (NASDAQ:BDSI) is positioning itself to enter that market as early as next year. BDSI plans to file a new drug application for its opioid dependence treatment BEMA Buprenorphine in the first half of 2013. Like current market […]
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Could a female Viagra be developed? Sprout Pharmaceuticals wants to find out if it can make a so-called pink Viagra and it’s picking up where German pharmaceutical company Boehringer Ingelheim left off. Sprout acquired flibanserin, a compound that Boehringer pursued as a drug to treat hypoactive sexual desire disorder, or HSDD — essentially, diminished sexual […]
Wellness programs that encourage workers to stop smoking or lose weight are showing up in more health insurance plans, state health plans included. But North Carolina’s State Health Plan took a different course this year. A comprehensive wellness plan introduced in 2009 was eliminated. Instead, the more than 664,000 teachers, state employees and retirees in […]
The cancer treatment portfolio of DARA BioSciences (NASDAQ:DARA) has added its third cancer product in as many months, a topical product to treat radiation and chemotherapy burns. DARA said that it has entered into an exclusive agreement with Charleston, South Carolina-based Innocutis Holdings for the U.S. rights of Bionect, a product that comes as […]
Healthcare reform discussion about healthcare costs often turns to private insurance plans. But state health plans have a stake in the matter too, and in some ways they’re more vulnerable. State workers are less likely than their public sector counterparts to be uninsured. States also typically pay a higher share of the insurance premium compared […]
Gastrointestinal treatments firm Salix Pharmaceuticals (NASDAQ:SLXP) aims to raise $600 million in debt financing. The Raleigh, North Carolina company has priced the $600 million offering of convertible senior notes, which is open to qualified institutional investors. Salix could raise up to $90 million more if purchasers exercise overallotment options. Interest on the notes will be […]